{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:57:25Z","timestamp":1790290645372,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["CZ.02.01.01\/00\/22_008\/0004607"],"award-info":[{"award-number":["CZ.02.01.01\/00\/22_008\/0004607"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejps.2025.107281","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:02:04Z","timestamp":1758585724000},"page":"107281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Selective formation of coamorphous systems with enzalutamide: Benzene rings as key structural features"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4004-6818","authenticated-orcid":false,"given":"Argyro","family":"Chatziadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Neubergerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Krishna Rao","family":"Balaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Trunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"\u0160o\u00f3\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107281_bib0001","doi-asserted-by":"crossref","unstructured":"Abaszadeh, F., Ashoub, M.H., Amiri, M., 2023. Nanoemulsions challenges and future prospects as a drug delivery system 217\u2013243. https:\/\/doi.org\/10.1007\/978-981-99-5398-1_13.","DOI":"10.1007\/978-981-99-5398-1_13"},{"key":"10.1016\/j.ejps.2025.107281_bib0002","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1021\/acs.cgd.2c00207","article-title":"Characterization and insights into the formation of new multicomponent solid forms of sofosbuvir","volume":"22","author":"Chatziadi","year":"2022","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107281_bib0003","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s13346-018-0479-7","article-title":"Continuous manufacturing of co-crystals: challenges and prospects","volume":"8","author":"Chavan","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107281_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2015.12.009","article-title":"Recent advances in co-amorphous drug formulations","author":"Dengale","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107281_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2015.12.009","article-title":"Recent advances in co-amorphous drug formulations","author":"Dengale","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107281_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030134","article-title":"Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability","author":"Gigliobianco","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107281_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122333","article-title":"A comparative study on in vitro and in vivo characteristics of enzalutamide nanocrystals versus amorphous solid dispersions and a better prediction for bioavailability based on \u201cspring-parachute\u201d model","volume":"628","author":"Guo","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107281_bib0008","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-12-2910","article-title":"Enzalutamide: A novel antiandrogen for patients with castrate-resistant prostate cancer","author":"Hoffman-Censits","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2025.107281_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00607-4","article-title":"Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy","volume":"18","author":"Jiang","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejps.2025.107281_bib0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijpharm.2018.12.036","article-title":"Co-former selection for co-amorphous drug-amino acid formulations","volume":"557","author":"Kasten","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107281_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081318","article-title":"Recent technologies for amorphization of poorly water-soluble drugs","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107281_bib0012","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/pharmaceutics11120628","article-title":"Determination of stable co-amorphous drug\u2013drug ratios from the eutectic behavior of crystalline physical mixtures","volume":"11","author":"Kissi","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107281_bib0013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1208\/s12249-015-0393-y","article-title":"Challenges and strategies in thermal processing of amorphous solid dispersions: a review","volume":"17","author":"LaFountaine","year":"2016","journal-title":"AAPS. PharmSciTech."},{"key":"10.1016\/j.ejps.2025.107281_bib0014","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2012.04.066","article-title":"Emerging trends in the stabilization of amorphous drugs","volume":"453","author":"Laitinen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107281_bib0015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/ijms25021197","article-title":"Enhanced stability and improved oral absorption of enzalutamide with self-nanoemulsifying drug delivery system","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107281_bib0016","first-page":"82","article-title":"Poor aqueous solubility - An industry wide problem in drug discovery","volume":"5","author":"Lipinski","year":"2002","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.ejps.2025.107281_bib0017","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2012.02.004","article-title":"Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions","volume":"81","author":"L\u00f6bmann","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107281_bib0018","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1107\/S205225251700848X","article-title":"CrystalExplorer model energies and energy frameworks: Extension to metal coordination compounds, organic salts, solvates and open-shell systems","volume":"4","author":"Mackenzie","year":"2017","journal-title":"IUCrJ"},{"key":"10.1016\/j.ejps.2025.107281_bib0019","doi-asserted-by":"crossref","DOI":"10.1107\/S0021889807067908","article-title":"Mercury CSD 2.0 - New features for the visualization and investigation of crystal structures","author":"Macrae","year":"2008","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejps.2025.107281_bib0020","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1021\/acs.cgd.7b01613","article-title":"Crystal Forms of Enzalutamide and a Crystal Engineering Route to Drug Purification","volume":"18","author":"Maini","year":"2018","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107281_bib0021","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/acs.molpharmaceut.4c01276","article-title":"Is there polyamorphism in amorphous indomethacin? Investigating the physicochemical properties of amorphous indomethacin with different thermal history","volume":"22","author":"Musumeci","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107281_bib0022","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1021\/acs.cgd.2c00883","article-title":"Cocrystal and coamorphous solid forms of enzalutamide with saccharin: structural characterization and dissolution studies","volume":"22","author":"Prashanth","year":"2022","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107281_bib0023","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1021\/acs.cgd.2c00883","article-title":"Cocrystal and coamorphous solid forms of enzalutamide with saccharin: structural characterization and dissolution studies","volume":"22","author":"Prashanth","year":"2022","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107281_bib0024","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1021\/acs.cgd.2c00883","article-title":"Cocrystal and coamorphous solid forms of enzalutamide with saccharin: structural characterization and dissolution studies","volume":"22","author":"Prashanth","year":"2022","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2025.107281_bib0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tca.2018.05.020","article-title":"Amorphous enzalutamide \u2013 non-isothermal recrystallization kinetics and thermal stability","volume":"665","author":"Romanov\u00e1","year":"2018","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejps.2025.107281_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tca.2018.05.020","article-title":"Amorphous Enzalutamide \u2013 Non-isothermal recrystallization kinetics and thermal stability","volume":"665","author":"Romanov\u00e1","year":"2018","journal-title":"Thermochim Acta"},{"key":"10.1016\/j.ejps.2025.107281_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2006.11.016","article-title":"Microemulsions as carriers for drugs and nutraceuticals","author":"Spernath","year":"2006","journal-title":"Adv. Colloid. Interface Sci."},{"key":"10.1016\/j.ejps.2025.107281_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2016.01.012","article-title":"Amorphous solid dispersions: rational selection of a manufacturing process","author":"Vasconcelos","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107281_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.114937","article-title":"Effect of polymers and cyclodextrins on solubility, permeability and distribution of enzalutamide and apalutamide antiandrogens","volume":"322","author":"Volkova","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejps.2025.107281_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-75077-7","article-title":"Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance","volume":"10","author":"Wilson","year":"2020","journal-title":"Sci. Rep."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:21:47Z","timestamp":1773130907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725002799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"alternative-id":["S0928098725002799"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107281","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective formation of coamorphous systems with enzalutamide: Benzene rings as key structural features","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107281"}}